Literature DB >> 12600978

Effects of blood-processing protocols on cell-free DNA quantification in plasma.

Dorine W Swinkels, Erwin Wiegerinck, Eric A P Steegers, Jacques B de Kok.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12600978     DOI： 10.1373/49.3.525

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  24 in total

1.  Liquid Biopsy in Breast Cancer: Circulating Tumor Cells and Circulating Tumor DNA.

Authors:  Tae-Kyung Yoo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions.

Authors:  Laure Sorber; Karen Zwaenepoel; Julie Jacobs; Koen De Winne; Kaat Van Casteren; Elien Augustus; Filip Lardon; Hans Prenen; Marc Peeters; Jan Van Meerbeeck; Geert Roeyen; Christian Rolfo; Patrick Pauwels
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

Review 3.  Integrating liquid biopsies into the management of cancer.

Authors:  Giulia Siravegna; Silvia Marsoni; Salvatore Siena; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2017-03-02       Impact factor: 66.675

4.  Evidence-based best practices for EGFR T790M testing in lung cancer in Canada.

Authors:  T Stockley; C A Souza; P K Cheema; B Melosky; S Kamel-Reid; M S Tsao; A Spatz; A Karsan
Journal:  Curr Oncol       Date:  2018-04-30       Impact factor: 3.677

5.  Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients.

Authors:  Katri Saukkonen; Päivi Lakkisto; Marjut Varpula; Tero Varpula; Liisa-Maria Voipio-Pulkki; Ville Pettilä; Kari Pulkki
Journal:  Intensive Care Med       Date:  2007-05-31       Impact factor: 17.440

6.  "Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical Trials.

Authors:  Matthew J Murray; Hannah L Watson; Dawn Ward; Shivani Bailey; Marta Ferraresso; James C Nicholson; Vincent J Gnanapragasam; Benjamin Thomas; Cinzia G Scarpini; Nicholas Coleman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-12-18       Impact factor: 4.254

7.  Plasma cell-free DNA in patients needing mechanical ventilation.

Authors:  Marjatta Okkonen; Päivi Lakkisto; Anna-Maija Korhonen; Ilkka Parviai-nen; Matti Reinikainen; Tero Varpula; Ville Pettilä
Journal:  Crit Care       Date:  2011-08-12       Impact factor: 9.097

8.  The impact of chronic kidney disease and short-term treatment with rosiglitazone on plasma cell-free DNA levels.

Authors:  Amanda L McGuire; Nadia Urosevic; Doris T Chan; Gursharan Dogra; Timothy J J Inglis; Aron Chakera
Journal:  PPAR Res       Date:  2014-10-13       Impact factor: 4.964

9.  Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC).

Authors:  James L Sherwood; Claire Corcoran; Helen Brown; Alan D Sharpe; Milena Musilova; Alexander Kohlmann
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

10.  The potential for liquid biopsies in the precision medical treatment of breast cancer.

Authors:  Victoria A Forte; Dany K Barrak; Mostafa Elhodaky; Lily Tung; Anson Snow; Julie E Lang
Journal:  Cancer Biol Med       Date:  2016-03       Impact factor: 4.248
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.